Skip to main content
. 2013 Sep 30;19(3):195–209. doi: 10.3350/cmh.2013.19.3.195

Table 1.

In vitro drug susceptibility and cross resistance of antiviral-resistant HBV1,2,6

graphic file with name cmh-19-195-i001.jpg

LAM, lamivudine; CLV, clevudine; LDT, telbivudine; ETV, entecavir; ADV, adefovir; TDF, tenofovir; L-NA, L-nucleoside analogues (LAM, LDT, CLV), NA; not available.